Century Therapeutics IPSC
NASDAQ IPSC
$1.61 -0.10 (-5.85%)
At close: Oct 1, 2026 · 4:00 PM EDT

Century Therapeutics (IPSC) Cash & Equivalents (2020 - 2026)

Updated

Century Therapeutics' Cash & Equivalents was $49.64 million in Q2 2026, down 12.7% from $56.88 million a year earlier and down 2.8% from the prior quarter.

Analysis

Century Therapeutics (IPSC) Cash & Equivalents (2020 - 2026) Analysis & Trends

At the end of FY2025, Cash & Equivalents at Century Therapeutics came in at $61.85 million, up 5.8% from FY2024.

  • Cash & Equivalents shows a five-year compound annual growth rate of 17.8% (FY2020 to FY2025).
  • In earlier years, Cash & Equivalents was $58.44 million in FY2024 (+23.5%), $47.32 million in FY2023 (-43.8%), $84.27 million in FY2022 (+49.3%) and $56.45 million in FY2021 (+107.4%).
  • The Q2 2026 figure marks the lowest quarterly Cash & Equivalents since Q2 2024.
  • Compared with a year earlier, Cash & Equivalents was higher in five of the last eight quarters, with growth averaging 8.0%.
  • The best year-over-year quarter for Cash & Equivalents over five years was Q4 2021 (growth of 107.4%); the worst was Q2 2022 (a decline of 58.6%).
  • Per Business Quant data, IPSC's Cash & Equivalents in the three quarters before Q2 2026 was $51.05 million (Q1 2026), $61.85 million (Q4 2025) and $55.52 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 20.42 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 6.57 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 6.85 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 7.62 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 4.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 13.99 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.18 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 976.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 6.14 Bn
10 Century Therapeutics 308.74 Mn -195.64 Mn - 49.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 49.64 Mn
Mar 31, 2026 51.05 Mn
Dec 31, 2025 61.85 Mn
Sep 30, 2025 55.52 Mn
Jun 30, 2025 56.88 Mn
Mar 31, 2025 51.87 Mn
Dec 31, 2024 58.44 Mn
Sep 30, 2024 52.59 Mn
Jun 30, 2024 41.46 Mn
Mar 31, 2024 46.81 Mn
Dec 31, 2023 47.32 Mn
Sep 30, 2023 55.31 Mn
Jun 30, 2023 64.44 Mn
Mar 31, 2023 86.83 Mn
Dec 31, 2022 84.27 Mn
Sep 30, 2022 111.35 Mn
Jun 30, 2022 112.79 Mn
Mar 31, 2022 126.04 Mn
Dec 31, 2021 56.45 Mn
Sep 30, 2021 101.29 Mn
API Access

Century Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IPSC&period=max&api_key=YOUR_API_KEY